Reducing Implant Infection in Orthopaedics (RIIiO): Results of a pilot study comparing the influence of forced air and resistive fabric warming technologies on postoperative infections following orthopaedic implant surgery.


Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 29 07 2019
accepted: 28 08 2019
pubmed: 8 9 2019
medline: 1 4 2020
entrez: 8 9 2019
Statut: ppublish

Résumé

Active warming during surgery prevents perioperative hypothermia but the effectiveness and postoperative infection rates may differ between warming technologies. To establish the recruitment and data management strategies needed for a full trial comparing postoperative infection rates associated with forced air warming (FAW) versus resistive fabric warming (RFW) in patients aged >65 years undergoing hemiarthroplasty following fractured neck of femur. Participants were randomized 1:1 in permuted blocks to FAW or RFW. Hypothermia was defined as a temperature of <36°C at the end of surgery. Primary outcomes were the number of participants recruited and the number with definitive deep surgical site infections. A total of 515 participants were randomized at six sites over a period of 18 months. Follow-up was completed for 70.1%. Thirty-seven participants were hypothermic (7.5% in the FAW group; 9.7% in the RFW group). The mean temperatures before anaesthesia and at the end of surgery were similar. For the primary clinical outcome, there were four deep surgical site infections in the FAW group and three in the RFW group. All participants who developed a postoperative infection had antibiotic prophylaxis, a cemented prosthesis, and were operated under laminar airflow; none was hypothermic. There were no serious adverse events related to warming. Surgical site infections were identified in both groups. Progression from the pilot to the full trial is possible but will need to take account of the high attrition rate.

Sections du résumé

BACKGROUND BACKGROUND
Active warming during surgery prevents perioperative hypothermia but the effectiveness and postoperative infection rates may differ between warming technologies.
AIM OBJECTIVE
To establish the recruitment and data management strategies needed for a full trial comparing postoperative infection rates associated with forced air warming (FAW) versus resistive fabric warming (RFW) in patients aged >65 years undergoing hemiarthroplasty following fractured neck of femur.
METHODS METHODS
Participants were randomized 1:1 in permuted blocks to FAW or RFW. Hypothermia was defined as a temperature of <36°C at the end of surgery. Primary outcomes were the number of participants recruited and the number with definitive deep surgical site infections.
FINDINGS RESULTS
A total of 515 participants were randomized at six sites over a period of 18 months. Follow-up was completed for 70.1%. Thirty-seven participants were hypothermic (7.5% in the FAW group; 9.7% in the RFW group). The mean temperatures before anaesthesia and at the end of surgery were similar. For the primary clinical outcome, there were four deep surgical site infections in the FAW group and three in the RFW group. All participants who developed a postoperative infection had antibiotic prophylaxis, a cemented prosthesis, and were operated under laminar airflow; none was hypothermic. There were no serious adverse events related to warming.
CONCLUSION CONCLUSIONS
Surgical site infections were identified in both groups. Progression from the pilot to the full trial is possible but will need to take account of the high attrition rate.

Identifiants

pubmed: 31493477
pii: S0195-6701(19)30354-8
doi: 10.1016/j.jhin.2019.08.019
pii:
doi:

Types de publication

Comparative Study Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

412-419

Informations de copyright

Copyright © 2019 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Auteurs

M Kümin (M)

Nuffield Department of Medicine, University of Oxford, Oxford, UK.

J Deery (J)

East Kent Hospitals University NHS Foundation Trust, Canterbury, UK.

S Turney (S)

East Kent Hospitals University NHS Foundation Trust, Canterbury, UK.

C Price (C)

East Kent Hospitals University NHS Foundation Trust, Canterbury, UK.

P Vinayakam (P)

East Kent Hospitals University NHS Foundation Trust, Canterbury, UK.

A Smith (A)

East Kent Hospitals University NHS Foundation Trust, Canterbury, UK.

A Filippa (A)

Heart of England NHS Foundation Trust, Birmingham, UK.

L Wilkinson-Guy (L)

Heart of England NHS Foundation Trust, Birmingham, UK.

F Moore (F)

Heart of England NHS Foundation Trust, Birmingham, UK.

M O'Sullivan (M)

Heart of England NHS Foundation Trust, Birmingham, UK.

M Dunbar (M)

Heart of England NHS Foundation Trust, Birmingham, UK.

J Gaylard (J)

Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.

J Newman (J)

Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.

C M Harper (CM)

Brighton and Sussex University Hospitals NHS Trust, Brighton, UK; Brighton and Sussex Medical School, Brighton, UK.

D Minney (D)

Milton Keynes University Hospitals NHS Foundation Trust, Milton Keynes, UK.

C Parkin (C)

Milton Keynes University Hospitals NHS Foundation Trust, Milton Keynes, UK.

L Mew (L)

Milton Keynes University Hospitals NHS Foundation Trust, Milton Keynes, UK.

O Pearce (O)

Milton Keynes University Hospitals NHS Foundation Trust, Milton Keynes, UK.

K Third (K)

Northumbria Healthcare NHS Foundation Trust, Newcastle Upon Tyne, UK.

H Shirley (H)

Northumbria Healthcare NHS Foundation Trust, Newcastle Upon Tyne, UK.

M Reed (M)

Northumbria Healthcare NHS Foundation Trust, Newcastle Upon Tyne, UK.

L Jefferies (L)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

J Hewitt-Gray (J)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

C Scarborough (C)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

D Lambert (D)

Brighton and Sussex Medical School, Brighton, UK.

C I Jones (CI)

Brighton and Sussex Medical School, Brighton, UK.

S Bremner (S)

Brighton and Sussex Medical School, Brighton, UK.

D Fatz (D)

Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.

N Perry (N)

Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.

M Costa (M)

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

M Scarborough (M)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: 436461.Matthew.Scarborough@ouh.nhs.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH